GBVAM as a Novel NHE1 Inhibitor Alleviates Doxorubicin-Induced Cardiotoxicity via PI3K/Akt/mTOR Pathway.
Saved in:
| Title: | GBVAM as a Novel NHE1 Inhibitor Alleviates Doxorubicin-Induced Cardiotoxicity via PI3K/Akt/mTOR Pathway. |
|---|---|
| Authors: | Xu Y; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China., Li Y; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China., Cheng Z; Department of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, People's Republic of China.; College of Pharmacy, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China., Shao C; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China., Zhao X; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China., Liu Y; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China., Gou X; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China., Li C; Department of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, People's Republic of China. |
| Source: | Drug design, development and therapy [Drug Des Devel Ther] 2026 May 12; Vol. 20, pp. 585989. Date of Electronic Publication: 2026 May 12 (Print Publication: 2026). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN: 1177-8881 (Electronic) Linking ISSN: 11778881 NLM ISO Abbreviation: Drug Des Devel Ther Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42148365 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: GBVAM as a Novel NHE1 Inhibitor Alleviates Doxorubicin-Induced Cardiotoxicity via PI3K/Akt/mTOR Pathway. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Xu+Y%22">Xu Y</searchLink>; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Li+Y%22">Li Y</searchLink>; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Cheng+Z%22">Cheng Z</searchLink>; Department of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, People's Republic of China.; College of Pharmacy, Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Shao+C%22">Shao C</searchLink>; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Zhao+X%22">Zhao X</searchLink>; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Liu+Y%22">Liu Y</searchLink>; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Gou+X%22">Gou X</searchLink>; School of Chemistry and Chemical Engineering, Tianjin University of Technology, Tianjin, People's Republic of China.<br /><searchLink fieldCode="AU" term="%22Li+C%22">Li C</searchLink>; Department of Pharmacy, Hebei Medical University Third Hospital, Shijiazhuang, Hebei, People's Republic of China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101475745%22">Drug design, development and therapy</searchLink> [Drug Des Devel Ther] 2026 May 12; Vol. 20, pp. 585989. <i>Date of Electronic Publication: </i>2026 May 12 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Press+Limited%22">Dove Press Limited </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101475745 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1177-8881 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211778881%22">11778881 </searchLink><i>NLM ISO Abbreviation: </i>Drug Des Devel Ther <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42148365 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.2147/DDDT.S585989 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 585989 Titles: – TitleFull: GBVAM as a Novel NHE1 Inhibitor Alleviates Doxorubicin-Induced Cardiotoxicity via PI3K/Akt/mTOR Pathway. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Xu Y – PersonEntity: Name: NameFull: Li Y – PersonEntity: Name: NameFull: Cheng Z – PersonEntity: Name: NameFull: Shao C – PersonEntity: Name: NameFull: Zhao X – PersonEntity: Name: NameFull: Liu Y – PersonEntity: Name: NameFull: Gou X – PersonEntity: Name: NameFull: Li C IsPartOfRelationships: – BibEntity: Dates: – D: 12 M: 05 Text: 2026 May 12 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1177-8881 Numbering: – Type: volume Value: 20 Titles: – TitleFull: Drug design, development and therapy Type: main |
| ResultId | 1 |
